- 7.
Heier MS. Narkolepsi hos barn – en diagnostisk og terapeutisk utfordring. Tidsskr Nor Lægeforen 1998; 118: 2691 – 3.
- 8.
Aran A, Einen M, Lin L et al. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010; 33: 1457 – 64. [PubMed]
- 10.
Poli F, Pizza F, Mignot E et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep 2013; 36: 175 – 81. [PubMed]
- 13.
Knudsen S, Jennum PJ, Alving J et al. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 2010; 33: 169 – 76. [PubMed]
- 15.
Heier MS, Evsiukova T, Vilming S et al. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep 2007; 30: 969 – 73. [PubMed]
- 16.
Mignot E, Hayduk R, Black J et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997; 20: 1012 – 20. [PubMed]
- 17.
Aran A, Lin L, Nevsimalova S et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009; 32: 979 – 83. [PubMed]
- 20.
Heier MS, Gautvik KM, Wannag E et al. Narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013; doi:10.1016/j,sleep.2013.03.020.
- 21.
Retningslinjer for utredning og behandling av barn og ungdom med narkolepsi. Oslo: Nasjonalt kompetansesenter for AD/HD, Tourettes syndrom og narkolepsi, 2013. www.nasjkomp.no og www.helsedirektoratet.no (30.4.2013).
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.